Ketek will eventually be severely curtailed or go off the market

Ketek will eventually be severely curtailed or go off the market.

You'll soon see a Ketek MedGuide for patients. And there's a lot of talk of a black box warning about hepatic risk.

FDA will also reconsider Ketek's indications for sinusitis and bronchitis. These less serious infections don't justify the risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote